Ubiquitin-specific protease 54 regulates GLUT1-mediated aerobic glycolysis to inhibit lung adenocarcinoma progression by modifying p53 degradation

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209–49.

Article  PubMed  Google Scholar 

Succony L, Rassl DM, Barker AP, McCaughan FM, Rintoul RC. Adenocarcinoma spectrum lesions of the lung: Detection, pathology and treatment strategies. Cancer Treat Rev. 2021;99:102237.

Article  CAS  PubMed  Google Scholar 

Thai AA, Solomon BJ, Sequist LV, Gainor JF, Heist RS. Lung cancer. Lancet. 2021;398:535–54.

Article  PubMed  Google Scholar 

Schonenberger MJ, Kovacs WJ. Hypoxia signaling pathways: modulators of oxygen-related organelles. Front Cell Dev Biol. 2015;3:42.

Article  PubMed  PubMed Central  Google Scholar 

Nagao A, Kobayashi M, Koyasu S, Chow CCT, Harada H. HIF-1-Dependent Reprogramming of Glucose Metabolic Pathway of Cancer Cells and Its Therapeutic Significance. Int J Mol Sci. 2019;20:238.

Article  PubMed  PubMed Central  Google Scholar 

Bartrons R, Simon-Molas H, Rodriguez-Garcia A, Castano E, Navarro-Sabate A, Manzano A, et al. Fructose 2,6-Bisphosphate in Cancer Cell Metabolism. Front Oncol. 2018;8:331.

Article  PubMed  PubMed Central  Google Scholar 

Chen L, Yuan R, Wen C, Liu T, Feng Q, Deng X, et al. E3 ubiquitin ligase UBR5 promotes pancreatic cancer growth and aerobic glycolysis by downregulating FBP1 via destabilization of C/EBPalpha. Oncogene. 2021;40:262–76.

Article  CAS  PubMed  Google Scholar 

Jeong H, Kim S, Hong BJ, Lee CJ, Kim YE, Bok S, et al. Tumor-Associated Macrophages Enhance Tumor Hypoxia and Aerobic Glycolysis. Cancer Res. 2019;79:795–806.

Article  CAS  PubMed  Google Scholar 

Bykov VJN, Eriksson SE, Bianchi J, Wiman KG. Targeting mutant p53 for efficient cancer therapy. Nat Rev Cancer. 2018;18:89–102.

Article  CAS  PubMed  Google Scholar 

Budanov AV. The role of tumor suppressor p53 in the antioxidant defense and metabolism. Subcell Biochem. 2014;85:337–58.

Article  PubMed  PubMed Central  Google Scholar 

Zhang C, Liu J, Xu D, Zhang T, Hu W, Feng Z. Gain-of-function mutant p53 in cancer progression and therapy. J Mol Cell Biol. 2020;12:674–87.

Article  PubMed  PubMed Central  Google Scholar 

Zhou X, Hao Q, Lu H. Mutant p53 in cancer therapy-the barrier or the path. J Mol Cell Biol. 2019;11:293–305.

Article  CAS  PubMed  Google Scholar 

Hassin O, Oren M. Drugging p53 in cancer: one protein, many targets. Nat Rev Drug Discov. 2023;22:127–44.

Article  CAS  PubMed  Google Scholar 

Xie Y, Wang M, Xia M, Guo Y, Zu X, Zhong J. Ubiquitination regulation of aerobic glycolysis in cancer. Life Sci. 2022;292:120322.

Article  CAS  PubMed  Google Scholar 

Komander D, Rape M. The ubiquitin code. Annu Rev Biochem. 2012;81:203–29.

Article  CAS  PubMed  Google Scholar 

Damgaard RB. The ubiquitin system: from cell signalling to disease biology and new therapeutic opportunities. Cell Death Differ. 2021;28:423–6.

Article  PubMed  PubMed Central  Google Scholar 

Asano Y, Matsumoto Y, Wada J, Rottapel R. E3-ubiquitin ligases and recent progress in osteoimmunology. Front Immunol. 2023;14:1120710.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cruz L, Soares P, Correia M. Ubiquitin-Specific Proteases: Players in Cancer Cellular Processes. Pharmaceuticals. 2021;14:848.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Harrigan JA, Jacq X, Martin NM, Jackson SP. Deubiquitylating enzymes and drug discovery: emerging opportunities. Nat Rev Drug Discov. 2018;17:57–78.

Article  CAS  PubMed  Google Scholar 

Philipson EH, Kuhnert BR, Pimentel R, Amini SB. Transient maternal hypotension following epidural anesthesia. Anesth Analg. 1989;69:604–7.

Article  CAS  PubMed  Google Scholar 

Zhong M, Jiang Q, Jin R. USP4 expression independently predicts favorable survival in lung adenocarcinoma. IUBMB Life. 2018;70:670–7.

Article  CAS  PubMed  Google Scholar 

Wang X, Xia S, Li H, Wang X, Li C, Chao Y, et al. The deubiquitinase USP10 regulates KLF4 stability and suppresses lung tumorigenesis. Cell Death Differ. 2020;27:1747–64.

Article  CAS  PubMed  Google Scholar 

Zhao X, Wu X, Wang H, Yu H, Wang J. USP53 promotes apoptosis and inhibits glycolysis in lung adenocarcinoma through FKBP51-AKT1 signaling. Mol Carcinog. 2020;59:1000–1011.

Article  CAS  PubMed  Google Scholar 

Zhao M, Xin XF, Zhang JY, Dai W, Lv TF, Song Y. LncRNA GMDS-AS1 inhibits lung adenocarcinoma development by regulating miR-96-5p/CYLD signaling. Cancer Med. 2020;9:1196–1208.

Article  CAS  PubMed  Google Scholar 

Park HB, Hwang S, Baek KH. USP7 regulates the ERK1/2 signaling pathway through deubiquitinating Raf-1 in lung adenocarcinoma. Cell Death Dis. 2022;13:698.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim Y, Shiba-Ishii A, Nakagawa T, Husni RE, Sakashita S, Takeuchi T, et al. Ubiquitin-specific protease 8 is a novel prognostic marker in early-stage lung adenocarcinoma. Pathol Int. 2017;67:292–301.

Article  CAS  PubMed  Google Scholar 

Han B, Sun Y, Yang D, Zhang H, Mo S, Chen X, et al. USP22 promotes development of lung adenocarcinoma through ubiquitination and immunosuppression. Aging. 2020;12:6990–7005.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu Y, Zhang Y, Wang D, Zhang Y, Zhang J, Zhang Y, et al. USP29 enhances chemotherapy-induced stemness in non-small cell lung cancer via stabilizing Snail1 in response to oxidative stress. Cell Death Dis. 2020;11:796.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pan J, Deng Q, Jiang C, Wang X, Niu T, Li H, et al. USP37 directly deubiquitinates and stabilizes c-Myc in lung cancer. Oncogene. 2015;34:3957–67.

Article  CAS  PubMed  Google Scholar 

Li J, Xiao X, Wang H, Wang W, Ou Y, Wang Z, et al. CDK4/6-USP51 axis regulates lung adenocarcinoma metastasis through ZEB1. Cancer Gene Ther. 2022;29:1181–92.

Article  CAS  PubMed  Google Scholar 

Fraile JM, Campos-Iglesias D, Rodriguez F, Espanol Y, Freije JM. The deubiquitinase USP54 is overexpressed in colorectal cancer stem cells and promotes intestinal tumorigenesis. Oncotarget. 2016;7:74427–34.

Article  PubMed  PubMed Central  Google Scholar 

Zhang C, Ma X, Wei G, Zhu X, Hu P, Chen X, et al. Centrosomal protein 120 promotes centrosome amplification and gastric cancer progression via USP54-mediated deubiquitination of PLK4. iScience. 2023;26:105745.

Article  CAS  PubMed  Google Scholar 

Pal A, Young MA, Donato NJ. Emerging potential of therapeutic targeting of ubiquitin-specific proteases in the treatment of cancer. Cancer Res. 2014;74:4955–66.

Article  CAS  PubMed  Google Scholar 

Zhao LY, Song J, Liu Y, Song CX, Yi C. Mapping the epigenetic modifications of DNA and RNA. Protein Cell. 2020;11:792–808.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nebbioso A, Tambaro FP, Dell’Aversana C, Altucci L. Cancer epigenetics: Moving forward. PLoS Genet. 2018;14:e1007362.

Article  PubMed  PubMed Central  Google Scholar 

Liu Y, Gu W. The complexity of p53-mediated metabolic regulation in tumor suppression. Semin Cancer Biol. 2022;85:4–32.

Article  CAS  PubMed  Google Scholar 

Li Q, Qin Y, Wei P, Lian P, Li Y, Xu Y, et al. Gas1 Inhibits Metastatic and Metabolic Phenotypes in Colorectal Carcinoma. Mol Cancer Res. 2016;14:830–40.

Article  CAS  PubMed 

Comments (0)

No login
gif